Cresco Labs Terminates Acquisition of VidaCann

Cresco Labs (CSE: CL) announced this morning that it is terminating its previously announced acquisition of VidaCann Ltd. The firms justification, in short, is that they simply don’t have the funds available to close the transaction, or to operate the resulting entity as the firm continues to face capital restrictions.

Concurrent with the announcement of the termination of the acquisition agreement, Cresco also announced that it will be selling additional properties in leaseback arrangements with Innovative Industrial Properties (NYSE: IIPR). The properties, located in Yellow Springs, Ohio, and Marshall, Michigan, will be sold for a combined US$38 million, includes certain undisclosed facility development funds as well. Cresco previously sold two Illinois properties to the same firm which also followed with triple net leaseback arrangements.

The fallout of the VidaCann arrangement is expected to reduce near term cash requirements by approximately $120 million. The acquisition for the Florida operating was pegged at $120 million when announced, and indicated to be comprised of both cash and shares, however within today’s announcement Cresco indicated that it was largely to be comprised of cash.

With these two announcements, we have effectively strengthened our balance sheet to the tune of nearly $158 millioni between new non-dilutive funding and the elimination of a significant near-term cash outlay earmarked for the Transaction. The team and operations at VidaCann are phenomenal, but with a focus on managing our cost of capital, and insuring the most efficient and highest return on invested capital, the ability to deploy resources to other, existing, Cresco markets that are widely considered some of the top markets in the US, like Illinois, Pennsylvania, California and Nevada, has to take priority.

Cresco Labs CEO and Co-founder Charlie Bachtell

The termination of Cresco Labs’ acquisition of VidaCann follows the amendment of the Origin House (CSE: OH) purchase announced two weeks ago.

Cambria Gold Mines — sponsored Sponsored · Cambria Gold Mines

Cresco Labs last traded at $7.62 on the CSE.


Information for this briefing was found via Sedar, Cresco Labs and Origin House. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Is Agnico Eagle Seabridge Gold’s Mystery Lender?

This Gold Giant Is Building 1.5 Million More Ounces a Year | Agnico Eagle Q3 Earnings

This Gold Giant Was a Mess. Now It’s Back! | Barrick Mining Q3 2026 Earnings

Recommended

Epic Gold Delivers Maiden 279,000 Ounce Inferred Resource at Wilson Project

First Phosphate Adds UK Export Finance to Growing Export Credit Lineup With C$220 Million Letter of Interest

Related News

Grizzly Research Targets IIPR, Claims Series Of Sham Transactions, Toxic Assets

Grizzly Research has released its latest short report this morning, this time targeting the cannabis-focused...

Thursday, April 9, 2020, 10:51:10 AM

Cresco Labs: Canaccord Bumps Price Target Up To $20.50

Wednesday, Canaccord came out with their updated valuations for the large three multi-state operators. With...

Sunday, January 17, 2021, 01:41:00 PM

Cresco Labs Completes US$90 Million Cure Pennsylvania Acquisition Deal

Cresco Labs (CSE: CL) disclosed on Thursday that it has closed the previously announced acquisition of...

Friday, November 26, 2021, 10:48:00 AM

Origin House Expects to Nearly Double First Quarter Revenues

Origin House (CSE: OH) announced preliminary revenue figures for the second quarter of 2019 today,...

Thursday, July 18, 2019, 11:07:06 AM

Cresco Labs Enters US$282.5 Million Purchase Agreement for Tryke Companies

Cresco Labs (CSE: CL) announced this morning that it has entered a purchase agreement to...

Monday, September 16, 2019, 09:08:24 AM